SCHEMBL2233200

SCHEMBL2233200

Cc1ccc(COc2ccc(Oc3c(C)cc(/C(=C\C(=O)O)CCC[Si](C)(C)C)cc3Cl)nc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.35
ALOX5AP P20292 1/20 0.35
THRA P10827 1/20 0.34
THRB P10828 1/20 0.34
ACACB O00763 3/20 0.34
ACACA Q13085 2/20 0.34
MAOB P27338 2/20 0.34
PPARG P37231 1/20 0.34
FFAR1 O14842 1/20 0.34
MRGPRX4 Q96LA9 2/20 0.33
P4HTM Q9NXG6 1/20 0.33
SLC26A4 O43511 1/20 0.33
KMT2A Q03164 1/20 0.33
PARP10 Q53GL7 1/20 0.33
CYP4F2 P78329 3/20 0.33
CYP4A11 Q02928 3/20 0.33
NR1H4 Q96RI1 1/20 0.33
PDPK1 O15530 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2231831 0.88 KMT2A (0.41) ALOX5ALOX5APMAOBFFAR1SLC26A4
SCHEMBL2234682 0.85 MAOB (0.41) THRATHRBACACBACACAMAOB
SCHEMBL2234686 0.85 MAOB (0.41) THRATHRBACACBACACAMAOB
SCHEMBL2234688 0.85 MAOB (0.41) THRATHRBACACBACACAMAOB
SCHEMBL2231791 0.84 PPARG (0.40) ALOX5ACACBACACAPPARGMRGPRX4
SCHEMBL2233197 0.83 MAOB (0.38) ALOX5ALOX5APTHRATHRBACACB
SCHEMBL2233202 0.83 MAOB (0.38) ALOX5ALOX5APTHRATHRBACACB
SCHEMBL13582311 0.79 MAOB (0.42) THRATHRBACACBACACAMAOB
SCHEMBL13582306 0.79 MAOB (0.42) THRATHRBACACBACACAMAOB
SCHEMBL13582309 0.79 MAOB (0.42) THRATHRBACACBACACAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011093524-A1 DI - SUBSTITUTED PYRIDINE DERIVATIVES AS ANTICANCERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2011-08-04 WO disclosed